111 related articles for article (PubMed ID: 1693037)
1. [Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate Part I: Nocturnal penile tumescence monitoring].
Kumamoto Y; Yamaguchi Y; Sato Y; Suzuki R; Tanda H; Kato S; Mori K; Matsumoto H; Maki A; Kadono M
Hinyokika Kiyo; 1990 Feb; 36(2):213-26. PubMed ID: 1693037
[TBL] [Abstract][Full Text] [Related]
2. [Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate. Part II: Self-assessment questionnaire method].
Kumamoto Y; Yamaguchi Y; Sato Y; Suzuki R; Tanda H; Kato S; Mori K; Matsumoto H; Maki A; Kadono M
Hinyokika Kiyo; 1990 Feb; 36(2):227-44. PubMed ID: 1693038
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method].
Shida K; Koyanagi T; Kawakura K; Nishida T; Kumamoto Y; Orikasa S; Sato S; Takeda M; Yamanaka H; Shimazaki J
Hinyokika Kiyo; 1986 Apr; 32(4):625-48. PubMed ID: 2426932
[TBL] [Abstract][Full Text] [Related]
4. A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group.
Akaza H; Usami M; Kotake T; Koiso K; Aso Y
Jpn J Clin Oncol; 1993 Jun; 23(3):178-85. PubMed ID: 7688829
[TBL] [Abstract][Full Text] [Related]
5. [Fundamental and clinical study of the anti-prostatic effect of allylestrenol].
Yamanaka H; Kosaku N; Makino T; Shida K
Hinyokika Kiyo; 1983 Sep; 29(9):1133-45. PubMed ID: 6203385
[TBL] [Abstract][Full Text] [Related]
6. [The preventive effect of indeloxazine hydrochloride to the sexual dysfunction caused by anti-androgenergic agent (allylestrenol)].
Horita H; Kumamoto Y; Satoh Y; Suzuki N; Wada H; Shibuya A; Adachi H; Kurohata T; Tsukamoto T
Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):1044-50. PubMed ID: 7541089
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effects of allylestrenol on prostatic hypertrophy].
Kohri K; Kurita T; Iguchi M; Kataoka K
Hinyokika Kiyo; 1986 Mar; 32(3):486-92. PubMed ID: 2425611
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of allylestrenol (Org AL-25) on patients with prostatic hypertrophy--transrectal ultrasonography and urodynamic examination].
Ohyama M; Tanifuji T; Haraguchi C; Fujii N; Higaki Y; Yoshida H; Imamura K
Hinyokika Kiyo; 1986 Apr; 32(4):649-59. PubMed ID: 2426933
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy].
Fukuoka H; Ishibashi Y; Shiba T; Tuchiya F; Sakanishi S
Hinyokika Kiyo; 1993 Jul; 39(7):679-83. PubMed ID: 7689782
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of CMA in the treatment of prostatic cancer].
Fukuoka H; Goto A; Murai T; Satomi Y; Moriyama M; Senga Y; Shirai K; Nakao H
Hinyokika Kiyo; 1986 Dec; 32(12):1821-30. PubMed ID: 2435131
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effect of allylestrenol on benign prostatic hypertrophy].
Tajima A; Aso Y; Ushiyama T; Hata M; Kambayashi T; Ohmi Y; Masuda H; Nakahara M; Kitagawa M; Suzuki A
Hinyokika Kiyo; 1986 Mar; 32(3):477-85. PubMed ID: 2425610
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
[TBL] [Abstract][Full Text] [Related]
15. Relationship between sleep-related erections and testosterone levels in men.
Granata AR; Rochira V; Lerchl A; Marrama P; Carani C
J Androl; 1997; 18(5):522-7. PubMed ID: 9349750
[TBL] [Abstract][Full Text] [Related]
16. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
[TBL] [Abstract][Full Text] [Related]
17. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
Gotanda K; Shinbo A; Okada M; Nakano Y; Kobayashi H; Sasaki T; Hagiwara M; Akaza H
Prostate Cancer Prostatic Dis; 2003; 6(1):66-72. PubMed ID: 12664069
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
20. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
Gratzke P; Kirby RS
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
